US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (194)
  • Diseases & Conditions (4012)
  • Drug Delivery (176)
  • Therapeutic Area (6273)
  • Vaccines (592)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
The Market for Personalized Gene Therapy Treatments for Cancer
12/23/2014 | published by: Kalorama Information
... research. It involves modification of genes instead of using a surgical method or chemical drug product. Essentially, gene therapies replace an abnormal gene with a normal gene, or changes the response of a gene (turn ...  |  read more...
USD 3,995
Active Pharmaceutical Ingredients (API) Market in India 2015-2019
1/14/2015 | published by: TechNavio - Infiniti Research Ltd.
... provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic ...  |  read more...
USD 3,000
Global Cancer Biomarkers Market 2015-2019
1/14/2015 | published by: TechNavio - Infiniti Research Ltd.
... Biomarkers are mostly used as diagnostic tools. Biomarkers help in identifying potential drug failures in initial stages, leading to savings in time and costs. Biomarkers are becoming an essential part of the drug discovery process. ...  |  read more...
USD 2,500
2015 Global Sexually-Transmitted Disease (STD) Market Outlook and Emerging Opportunities
1/13/2015 | published by: VPGMarketResearch.com
... Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales forecasts by country and market segment, ...  |  read more...
USD 9,600
2015 German Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
1/12/2015 | published by: VPGMarketResearch.com
... market during the next five years. The report examines trends in the German cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and ...  |  read more...
USD 6,800
2015 Spanish Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
1/12/2015 | published by: VPGMarketResearch.com
... market during the next five years. The report examines trends in the Spanish cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and ...  |  read more...
USD 6,800
2015 UK Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
1/12/2015 | published by: VPGMarketResearch.com
... market during the next five years. The report examines trends in the UK cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and ...  |  read more...
USD 6,800
2015 European Sexually-Transmitted Disease (STD): Market Outlook and Emerging Opportunities
1/13/2015 | published by: VPGMarketResearch.com
... market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in Europe (France, Germany, Italy, Spain, UK), Current scientific views on epidemiology and etiology are presented for Chancroid ...  |  read more...
USD 7,900
2015 European Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
1/12/2015 | published by: VPGMarketResearch.com
... help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major ...  |  read more...
USD 19,700
Pharmaceuticals in France: ISIC 2423
1/13/2015 | published by: Euromonitor International
... at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing ...  |  read more...
USD 600
OTC Medications in US (2014) – Market Sizes
1/21/2015 | published by: Mintel - Snapshots
... products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in US is given in USD with a minimum of ...  |  read more...
USD 600
OTC Medications in Italy (2014) – Market Sizes
1/21/2015 | published by: Mintel - Snapshots
... products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Italy is given in EUR with a minimum of ...  |  read more...
USD 600
Cuba Pharmaceuticals and Healthcare Report Q1 2015
1/7/2015 | published by: Business Monitor International
... in vaccine discoveries, as well as multinational agreements on medicinecommercialisation, have solidified Cuba's trajectory for further medical innovation. Therefore, Cuba willcontinue to offer profitable opportunities to foreign investors. Headline Expenditure Projections Pharmaceuticals: CUP1.35bn (USD1.35bn) in ...  |  read more...
USD 1,295
Czech Republic Pharmaceuticals and Healthcare Report Q1 2015
1/7/2015 | published by: Business Monitor International
... willcontinue until convergence. The healthcare spending of the Czech population remains superior to that ofthe less-developed markets of Eastern and South Eastern Europe, demonstrating that demand in theseregions will be even higher. However, the government's ...  |  read more...
USD 1,295
Mexico Pharmaceuticals and Healthcare Report Q1 2015
1/7/2015 | published by: Business Monitor International
... - driven bygovernment regulations supporting the sector and rising public awareness of off-patented medicines. Headline Expenditure Projections Pharmaceuticals: MXN172.74bn (USD13.53bn) in 2013 to MXN184.46bn (USD14.19bn) in 2014;+6.8% in local currency terms and +4.9% in US ...  |  read more...
USD 1,295
Puerto Rico Pharmaceuticals and Healthcare Report Q1 2015
1/7/2015 | published by: Business Monitor International
... companies are forced toconsolidate their manufacturing operations in the face of financial challenges. In the long term, Puerto Ricoremains an attractive destination for medicine production, as new and renewed investments will continue toenter the country. ...  |  read more...
USD 1,295
United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2015
1/7/2015 | published by: Business Monitor International
... expenditure on pharmaceuticals and continuedgovernment investment in the healthcare sector. Pharmaceutical companies with product portfolios gearedtowards the treatment of chronic diseases will be provided with a rapidly expanding patient base. However,we highlight that medicine price ...  |  read more...
USD 1,295
2015 France: Retail Sale of Pharmaceutical Goods In Spec. Stores-Industry Forecast report
1/5/2015 | published by: PerryHope Partners
... Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the number of enterprises, establishments, turnover and employment for 2015 and 2016 using regression analysis in our ...  |  read more...
USD 325
Central America Pharmaceuticals and Healthcare Report Q1 2015
1/14/2015 | published by: Business Monitor International
... for medicine development and manufacturing make the regionan attractive destination for drugmakers. Headline Expenditure Projections Pharmaceuticals: USD3.5bn in 2013 to USD3.7bn in 2014; +4.1%. Our forecast has been revisedslightly down since Q314 due to less ...  |  read more...
USD 1,945
Moldova Pharmaceuticals and Healthcare Report Q1 2015
1/14/2015 | published by: Business Monitor International
... pharmaceutical market tofeel the positive benefit of closer ties with the European Union. Moldova's economic outlook will continueto have a significant impact on the pharmaceutical market's growth trajectory over the forecast period. Headline Expenditure Projections ...  |  read more...
USD 1,945
Namibia Pharmaceuticals and Healthcare Report Q1 2015
1/14/2015 | published by: Business Monitor International
... [medicines] shortage' cast fresh doubt on thegovernment's commitment to tackle the pertinent healthcare issues that are affecting Namibians and leavingmany without adequate healthcare. Nevertheless, the government's plans to build new healthcare facilitiesand the recent recruitment ...  |  read more...
USD 1,945
Aspen Pharmacare Holdings Limited
1/21/2015 | published by: Dion Global Solutions
... area of operation and business segments, key facts and figures, key management and board structure, ownership pattern, shareholding statistics, revenue split by geography and business segments, financial performance and financial health snapshots through important ratios.  |  read more...
USD 50
Health Supplement Stores
1/19/2015 | published by: First Research, Inc.
... based in the US). Worldwide, annual sales of vitamins and dietary supplements through all channels total about $85 billion, according to Euromonitor. The US is the world's largest market and China is the fastest-growing. Growth ...  |  read more...
USD 129
Azerbaijan: Artificial Joints For Orthopedic Purposes - Market Report. Analysis and Forecast to 2020
1/20/2015 | published by: IndexBox Marketing Ltd.
... and trends in the industry.. It presents shows the sales data, allowing you to identify the key drivers and restraints You can find her strategic analysis of key factors influencing the market Forecasts illustrate how ...  |  read more...
USD 1,750
OTC Medications in Switzerland (2014) – Market Sizes
1/21/2015 | published by: Mintel - Snapshots
... products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Switzerland is given in CHF with a minimum of ...  |  read more...
USD 600
< prev 1    3  4  5  6  7  8  9  10